Moleculin Biotech, Inc. (NASDAQ: MBRX) is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The Company’s lead program, Annamycin is a next-generation anthracycline designed to avoid mu...
Use this information to figure out if this company is an ideal customer for you.
(713) 300-xxxx
2575 West Bellfort Boulevard
Houston, 77054
Moleculin Biotech Inc.'s CEO is Wally Klemp
Moleculin Biotech Inc.'s CMO is Robert Shepard
Moleculin Biotech Inc.'s CFO is Jonathan Foster
Moleculin Biotech Inc.'s HQ is located at 2575 West Bellfort Boulevard, Houston
Moleculin Biotech Inc.'s phone number is (713) 300-xxxx
Moleculin Biotech Inc.'s official website is moleculin.com
Moleculin Biotech Inc.'s revenue is $1M - $5M
Moleculin Biotech Inc. has 51 - 200 employees
Moleculin Biotech Inc. is in the industry of: Pharmaceuticals